Introduction of Caplacizumab into Subcutaneous Tissue, Percutaneous Approach, New Technology Group 5

XW013W5 ICD10-PCS Code is a billable and specific code that can be used to indicate the procedure of Introduction of Caplacizumab into Subcutaneous Tissue, Percutaneous Approach, New Technology Group 5 for reimbursement purposes. The 2023 edition of the American ICD-10-PCS code became effective on October 1, 2022.

Short description for XW013W5 ICD10-PCS code:

Introduce Caplacizumab in Subcu, Perc, New Tech 5